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"A continuing tide ofyoung people moving into research is cru-
cial to the vitality of science . .. Their enthusiastic curiosity is
the oxygen required to keep the flame bright. "
DR. DONALD S. FREDERICKSON
Former Director
National Institutes of Health
Scientist In The Making
THE ROCKEFELLER UNIVERSITY
RESEARCH
PROFILES
FALL 1981
Twenty-nine-year-old Alice Bendix Gottlieb, a "beeper"
tucked in the pocket of her white coat and a stethoscope
around her neck, looks much like other second-year medical
residents. Unlike most, however, her professional equipment
also includes a doctorate in immunology. In 1979, when she
stood up to receive her Ph. D. at The Rockefeller University,
her name was already attached to nine published papers. A
year later, Cornell University Medical College awarded her an
M.D. and the Sarah O'Laughlin Foley Prize in Clinical Medi-
cine. When she completes her residency next spring, she will
resume research at The Rockefeller University as part of a two-
year fellowship in rheumatology at the Hospital for Special
Surgery.
Dr. Gottlieb is a clinical sciencist in the making, a physi-
cian-researcher shuttling between the hospital ward and the
laboratory. She is a graduate of the joint Rockefeller-Cornell
M.D.-Ph.D. program, an extension of a commitment to clini-
cal research that began in 1910 when the then Rockefeller
Institute for Medical Research opened the councry's first hos-
pital devoted to the study of the basic science of human
disease.
As a child, reading biographies of famous medical
researchers of the past, many of whom were involved in
developing vaccines for immunization, Alice Bendix was
enthralled by the idea that the body can produce antibodies to
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protect itself against infectious organisms. Later she would
learn how radically contemporary immunology has changed
that simple picture. For one thing, researchers have discov-
ered that the immune defense system can itself become the
agent of disease through the process called autoimmunity-
rejection of "self." Among the conditions known or
suspected to be of autoimmune pathogenesis are rheumatoid
arthritis, myasthenia gravis, juvenile-onset diabetes, some
forms of hepatitis, and systemic lupus erythematosus. This
last has been under investigation at The Rockefeller Univer-
sity for a number of years as the prototype of the autoimmune
process, and was the major part of Alice Gottlieb's doctoral
research.
THE BITE OF THE WOLF
Lupus is the Latin word for wolf. Erythematosus refers to red-
dening of the skin caused by capillary congestion. Systemic
h,1pus erythematosus (SiE) was so named because of the cus-
tomary red rash on the face of its sufferers, which to diagnos-
ticians in the 19th century resembled the bite of a wolf. An
inflammatory disease, SLE can affect almost any organ in the
body- blood, brain, muscles, joints, kidneys, lungs, heart,
and skin. A mild form of lupus, called discoid, affects only the
skin. In its most serious form, SiE can be fatal. An estimated
half-million Americans have it. There are treatments of
varying degrees of effectiveness, but no preventive technique
or cure.
In normal immune function, an elaborate defense arsenal
rushes into action when outside antigens attack the body. Any
molecule the body perceives as foreign or "non-self" is called
an antigen. White blood cells, including lymphocytes, are the
principal defenders. B cells are lymphocytes that are believed
to be formed in the bone marrow. When activated they dif-
ferentiate into plasma cells that produce antibodies, which,
circulating through the blood, bind to antigens. (Vaccines are
derived from antigens. Vaccinations stimulate the body to
make antibodies which will then protect the body if it is
exposed to an attack by the microorganisms, such as bacteria
or viruses, that transmit those particular antigens in nature.)
T cells are also probably formed in the bone marrow but then
travel to the thymus, where they are processed to perform
other jobs. T cells are responsible for what is called cell-
mediated immunity, the rejection of foreign tissues, including
transplants. Another group of white cells, among them
macrophages and dendritic cells, are also part of the cell-
mediated system. The functions of the T and B lymphocytes,
although distinct, overlap. T cells modify the action of B cells
by facilitating or suppressing antibody production. The
macrophages are stimulated by antibodies to engulf invaders.
A group of enzymes in the blood, collectively called comple-
ment, are also activated by the antibodies and deliver the
chemical coup de grace to the antigens. When antibodies are
no longer needed, a signal goes out to stop production.
In the process of autoimmunity, antibodies pour forth and
attack the body's own molecules, binding to them as they
would to true antigens. As antibody and antigen bind
together, they form what is called an immune complex. By
studying patients with SLE, great advances have been made in
understanding how immune complexes cause tissue injury.
These patients produce a wide range of autoantibodies,
including those directed against their own DNA, RNA, ribo-
somes, red cells, and white cells. (DNA-deoxyribonucleic
acid-is the genetic material of the cell. RNA is a class of
nucleic acid with various functions, including conveying the
DN A message to the ribosomes, the cell components
involved in protein production.) Antibodies to DNA have
proven to be of special interest. Studies in Dr. Kunkel's labo-
ratory demonstrated that anti-DNA antibodies, in the form of
immune complexes, were concentrated in the glomeruli (fil-
tering apparatus) of kidneys from patients with SiE
nephritis-clearly demonstrating the role of autoantibodies
and immune complexes in the pathogenesis of this disease.
This discovery has been extended to other autoimmune dis-
eases such as rheumatoid arthritis.
"We know," Dr. Gottlieb points out, "that in normal indi-
viduals there can be low levels of autoantibodies, but in
patients with SiE, these levels are much higher and they actu-
ally cause significant tissue injury." Current research efforts
are focused on the abnormality of the immune regulatory sys-
tem that causes SLE patients to make such an abundance of
antibodies to their self-constituents.
"Studies of human disease are most difficult," says Dr.
Gottlieb, "and it is essential to acquire the best possible train-
ing." Hers began early, at New York's highly acclaimed
Bronx High School of Science. She earned her bachelor's
degree at Brandeis University (rom which she was graduated
summa cum laude (and where she met and married mathema-
tician Allan Gottlieb). At college, she majored in chemistry,
learning laboratory skills but acquiring little clinical experi-
ence. In her first year as a graduate fellow at Rockefeller Uni-
versity, she worked with Professor Richard M. Krause, who
has since become director of the National Institute of Allergy
and Infectious Diseases of the National Institutes of Health,
to master the basic techniques of immunology. With Dr.
Thomas]. Kindt, now also at NIH, she developed an
improved radioimmune assay for the study of antibody diver-
sity in experimental animals. Then she joined the laboratory
of Professor Henry G. Kunkel to apply her knowledge to the
study of human disease. Dr. Kunkel, Abby Rockefeller
Mauze Professor and a senior physician of The Rockefeller
University Hospital, has, in the words of one of his col-
leagues, "contributed more to the understanding of immun-
ologically mediated human diseases and basic principles of
human immunology than any other investigator in the field."
He is also a teacher with an exceptional capacity for recogniz-
ing and nurturing scientific talent.
TRACKING THE T CELLS
One of the studies Alice Gottlieb participated in during the
course of her training with Dr. Kunkel resulted in demon-
strating that SLE patients have impaired ability to respond to
outside antigens as the result of a defect in T-cell function.
This was learned by applying an in vitro (test tube) assay for
measuring the cellular immune response of the blood cells to
the antigen tetanus roxoid, a method that's been used in Dr.
Kunkel's laborarory to study a number of problems.
"When samples of blood from normal people are exposed
ro tetanus tOxoid" explains Dr. Gottlieb, "there is a marked
proliferation of T cells. This proliferation also involves the
presence of an accessory cell, the exact nature of which is still
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Glomerulus from the kidney ofa
patient with SLE nephritis that has
been treated with a fluorescent
anti-immunoglobulin antiserum. The
white areas show the deposition of
autoantibodies.
Lymphocytes.
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unknown. Some interesting research is going on in Zanvil
Cohn's laboratory to find out what this accessory cell is. (Pro-
fessor Zanvil A. Cohn is the leader of the University's labora-
tory of cellular physiology and immunology). In contrast, the
T cells from SiE patients showed a significant inability to pro-
liferate in response to antigenic stimulation. SiE patients
whose disease was inactive also showed the defect."
Was the defect in the T cells themselves or in the accessory
cells? With the help of Dr. Robert Lahita, a fellow laboratory
member, Dr. Gottlieb located families of "histocompatible"
siblings, one normal and one with SiE, to try to answer this
question. The world histocompatible refers to a biological
phenomenon of growing interest and importance in immun-
ological research. In cell-mediated immunity, the immune
system recognizes certain antigens on the surface of foreign
cells as non-self, in the same way it recognizes the foreign
nature of bacteria or viruses. The antigen molecules thus
recognized are called histocompatibility antigens, and they
differ from individual to individual. They are what gives the
tissues of each person his or her chemical identity, or biologi-
cal uniqeness. Except for identical twins, close or exact his-
tocompatible matches are rare.
"We found" says Dr. Gottlieb, "that SiE accessory cells
were perfectly able to cooperate with the histocompatible
normal T cells and give a good proliferating response to anti-
gen. But SiE T cells added to the normal accessory cells
could not. It was clear that the reason why the cell-mediated
immune function was defective was because the T cell was
defective. Further studies showed that the T-cell defect was
largely independent of adsorbed anti-lymphocyte antibody or
immune-complex inhibition or prostaglandin suppression of
T-cell function."
Another aspect of her thesis work included studying the
role of isolated B-cell subpopulations from normal individu-
als in various in vitro immune systems and comparing them
with the cells from patients with chronic lymphocytic leuke-
mia (CLL), a malignancy characterized by the overproduction
of surface immunoglobulin (sIg)-bearing B cells. (Immuno-
globulins are antibodies.) In association with Drs. James
Halper and Shu Man Fu, Dr. Gottlieb demonstrated marked
differences in the membrane properties of sIg-bearing B lym-
phocytes from the two sources. Qualitative differences of this
kind between malignant and normal cells may offer new leads
to our understanding of cancer.
AN IMPORTANT DECISION
The study of immune complex disorders fascinates scientists
like Dr. Gottlieb because there are so many facets to explore.
In SiE, for example, the incidence of disease is nine times
greater in women of child-bearing age than in men. In studies
with Professor Jack Fishman, head of Rockefeller Univer-
sity's endocrinology laboratory, it was observed that there is
also a high incidence of SiE among men with Kleinfelter's
disease, a condition in which there is an extra female compo-
nent on the chromosome. More recently Dr. iahita, in con-
tinued collaboration with Dr. Fishman's laboratory, has
shown that SiE patients have a higher than normal level of
metabolized estrogen, the female hormone. All of this
strongly suggests that estrogen plays a role in the manifesta-
tion of SLE, an area of investigation that is being vigorously
pursued. Then there remains the provocative matter of histo-
compatibility. Other research is underway to understand how
the presence of certain histocompatibility types relates to a
heightened immune-system response to a given antigen,
which occurs in normal individuals, as well as those with
autoimmune diseases.
There will be plenty for Alice Gottlieb to do when she
returns to the laboratory. In the meantime, she runs to hosp-
tial rounds, takes care of patients, and responds to calls on her
beeper. As she says: "Joining the M.D.-Ph.D. program and
having the opportunity to work at Rockefeller University was
one of the most important decisions I've ever made. The
deepest understanding is achieved when basic research is
applied to the study of disease states and, conversely, the
basic scientist with a knowledge of clinical medicine enjoys
the privilege of using these 'experiments of nature' to under-
stand normal human biology." 0
